Skip to content

A Crowd Sourcing Platform for Patients With Cancer

A Crowd Sourcing Platform for Patients With Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03530826
Enrollment
5000
Registered
2018-05-21
Start date
2018-04-26
Completion date
2028-01-31
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

Detailed description

The core hypothesis tested by this study is that engaging researchers, clinicians and patients in an online knowledge sharing platform will enable patients to better understand cancer, better inform treatment decisions made by oncologists and accelerate cancer research. Leftover samples from patients with cancer (blood, bodily fluids and/or tissues collected for clinical purposes) will be obtained and sent for various types of analyses and results will be shared on the All4Cure website.

Interventions

OTHERNo intervention

No Intervention

Sponsors

All4Cure
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have been diagnosed with cancer. * Be under the care of a physician. * Be 18 years of age or older.

Design outcomes

Primary

MeasureTime frameDescription
Change in tumor tissue molecular profiles6 yearsProfiles of pre- and post-treatment tumor tissue will be compared.

Countries

United States

Contacts

Primary ContactCarl A Blau, MD
tony@all4cure.com2064121787
Backup ContactKimberly A Burton, PhD
kaburton@all4cure.com2069482711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026